San Diego, CA, United States of America

Biovascular, Inc.


USPTO Granted Patents = 13

% Expired Patents = 30.8

Trademarks = 8

Forward Citations = 10,089

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Paul F Glidden (5 out of 8 patents)

silverMedal Kemal Schankereli (4 out of 44 patents)

bronzeMedal Joel Cooper (4 out of 4 patents)

4 Alison J Pilgrim (3 out of 3 patents)

5 Stephen R Hanson (3 out of 26 patents)

6 Robert P Nelson (3 out of 3 patents)

7 Sally L Winegar-Hentges (3 out of 3 patents)

8 Kristine M Teich (3 out of 3 patents)

9 Ralph T Francis (2 out of 3 patents)

10 Anne E Claeson (2 out of 2 patents)

11 B Nicholas Oray (1 out of 5 patents)

12 Amy DeSmith (1 out of 2 patents)

13 Qing Hong Zhao (1 out of 2 patents)

14 Thomas Odland (1 out of 1 patent)

15 Daniel G Holman (1 out of 1 patent)


13 patents:

Biovascular, Inc. is a leading biotechnology company focused on the development and commercialization of innovative vascular therapy solutions. With a strong commitment to improving patient outcomes, Biovascular is dedicated to advancing the field of vascular medicine through cutting-edge research and technology. The company's groundbreaking products have revolutionized the treatment of cardiovascular diseases and have earned acclaim from healthcare professionals worldwide. Biovascular's mission is to provide effective and sustainable solutions for vascular health, ultimately improving the lives of patients everywhere.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

13 Patents

#409 in San Diego, CA

#5,646 in California

#23,794 in US

#44,921 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 10,089

16 inventors:

Please report any incorrect information to [email protected]
Loading…